Group One Trading’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,400
| Closed | -$12.9K | – | 8295 |
|
|
2025
Q3 | $12.9K | Sell |
2,400
-12,200
| -84% | -$66K | ﹤0.01% | 7013 |
|
|
2025
Q2 | $79.3K | Buy |
14,600
+13,300
| +1,023% | +$52.7K | ﹤0.01% | 5180 |
|
|
2025
Q1 | $3.6K | Sell |
1,300
-44,700
| -97% | -$156K | ﹤0.01% | 6779 |
|
|
2024
Q4 | $157K | Buy |
46,000
+35,100
| +322% | +$101K | ﹤0.01% | 4127 |
|
|
2024
Q3 | $32K | Sell |
10,900
-144,000
| -93% | -$474K | ﹤0.01% | 4950 |
|
|
2024
Q2 | $527K | Sell |
154,900
-9,900
| -6% | -$32.4K | ﹤0.01% | 2518 |
|
|
2024
Q1 | $499K | Sell |
164,800
-9,300
| -5% | -$32.6K | ﹤0.01% | 2719 |
|
|
2023
Q4 | $733K | Buy |
174,100
+138,600
| +390% | +$752K | ﹤0.01% | 2746 |
|
|
2023
Q3 | $242K | Sell |
35,500
-26,800
| -43% | -$237K | ﹤0.01% | 3642 |
|
|
2023
Q2 | $649K | Buy |
62,300
+36,200
| +139% | +$324K | ﹤0.01% | 2760 |
|
|
2023
Q1 | $182K | Buy |
26,100
+2,500
| +11% | +$21.8K | ﹤0.01% | 3767 |
|
|
2022
Q4 | $142K | Sell |
23,600
-51,300
| -68% | -$379K | ﹤0.01% | 4135 |
|
|
2022
Q3 | $590K | Sell |
74,900
-55,200
| -42% | -$644K | ﹤0.01% | 3075 |
|
|
2022
Q2 | $1.77M | Sell |
130,100
-24,200
| -16% | -$400K | ﹤0.01% | 2169 |
|
|
2022
Q1 | $3.03M | Sell |
154,300
-22,300
| -13% | -$445K | ﹤0.01% | 1983 |
|
|
2021
Q4 | $6.06M | Sell |
176,600
-190,000
| -52% | -$7.64M | ﹤0.01% | 1536 |
|
|
2021
Q3 | $20M | Sell |
366,600
-62,400
| -15% | -$3.76M | 0.02% | 618 |
|
|
2021
Q2 | $31.5M | Buy |
429,000
+179,100
| +72% | +$17.9M | 0.04% | 398 |
|
|
2021
Q1 | $22.9M | Buy |
249,900
+178,500
| +250% | +$17.3M | 0.03% | 481 |
|
|
2020
Q4 | $5.79M | Buy |
+71,400
| New | +$5.47M | 0.01% | 1170 |
|
Group One Trading's CVAC Position: Q1 2026 in Review
Group One Trading sold out of CureVac (CVAC) in Q1 2026, closing a stake of 1,050 shares — an estimated $4.75K sold.
Group One Trading first reported a position in CVAC in Q4 2020 and held it in 19 quarters. The position peaked at $11.8M in Q3 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Group One Trading reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 1,050 CureVac shares in Q1 2026, an estimated $4.75K.
- Group One Trading first reported a position in CureVac in Q4 2020 and held it in 19 quarters.
- Group One Trading's CureVac position peaked at $11.8M in Q3 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.